Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 134,797 | $0.1998 | $26,932 | 0 (Direct) | View |
| 2024-09-10 Purchase | 2024-09-12 5:00 pm | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 100,000 | $1.6068 | $160,680 | 122,504 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-31 Tax Withholding | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 8,707 | $2.09 | 130,797 (Direct) | View |
| 2024-10-31 Exercise | 2024-11-04 5:01 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 17,000 | $0 | 130,797 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 13,666 | $0 | 49,838 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 3,500 | $5.12 | 49,838 (Direct) | View |
| 2023-12-02 Option Award | 2023-12-05 5:28 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley President & CEO | 86,000 | $0 | 86,000 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:51 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 17,000 | $0 | 29,338 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-02 4:51 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 6,004 | $2.22 | 29,338 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-04 6:56 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 658 | $2.58 | 7,342 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 6:56 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 2,000 | $0 | 7,342 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:19 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-10-06 Option Award(A) | 2022-10-11 4:55 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:40 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 78,500 | $0 | 78,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:09 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 180,000 | $0 | 180,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-09-28 4:24 pm | N/A 2031-09-26 | Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer | 360,000 | $0 | 360,000 (Direct) | View |